• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖病史、体格检查、实验室检查、身体成分和能量消耗:肥胖医学协会(OMA)2022年临床实践声明(CPS)

Obesity history, physical exam, laboratory, body composition, and energy expenditure: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.

作者信息

Burridge Karlijn, Christensen Sandra M, Golden Angela, Ingersoll Amy B, Tondt Justin, Bays Harold E

机构信息

Gaining Health, 528 Pennsylvania Ave #708 Glen Ellyn, IL 60137, USA.

Integrative Medical Weight Management, 2611 NE 125th St., Suite 100B, Seattle, WA, 98125, USA.

出版信息

Obes Pillars. 2022 Jan 10;1:100007. doi: 10.1016/j.obpill.2021.100007. eCollection 2022 Mar.

DOI:10.1016/j.obpill.2021.100007
PMID:37990700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10661987/
Abstract

BACKGROUND

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) on History, Physical Exam, Body Composition and Energy Expenditure is intended to provide clinicians an overview of the clinical and diagnostic evaluation of patients with pre-obesity/obesity.

METHODS

The scientific information for this CPS is based upon published scientific citations, clinical perspectives of OMA authors, and peer review by the Obesity Medicine Association leadership.

RESULTS

This CPS outlines important components of medical, dietary, and physical activity history as well as physical exams, with a focus on specific aspects unique to managing patients with pre-obesity or obesity. Patients with pre-obesity/obesity benefit from the same preventive care and general laboratory testing as those without an increase in body fat. In addition, patients with pre-obesity/obesity may benefit from adiposity-specific diagnostic testing - both generally and individually - according to patient presentation and clinical judgment. Body composition testing, such as dual energy x-ray absorptiometry, bioelectrical impedance, and other measures, each have their own advantages and disadvantages. Some patients in clinical research, and perhaps even clinical practice, may benefit from an assessment of energy expenditure. This can be achieved by several methods including direct calorimetry, indirect calorimetry, doubly labeled water, or estimated by equations. Finally, a unifying theme regarding the etiology of pre-obesity/obesity and effectiveness of treatments of obesity centers on the role of biologic and behavior efficiencies and inefficiencies, with efficiencies more often associated with increases in fat mass and inefficiencies more often associated with decreases in fat mass.

CONCLUSION

The Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) on History, Physical Exam, Body Composition and Energy Expenditure is one of a series of OMA CPSs designed to assist clinicians in the care of patients with the disease of pre-obesity/obesity.

摘要

背景

本肥胖医学协会(OMA)关于病史、体格检查、身体成分和能量消耗的临床实践声明(CPS)旨在为临床医生提供对肥胖前期/肥胖患者进行临床和诊断评估的概述。

方法

本CPS的科学信息基于已发表的科学文献引用、OMA作者的临床观点以及肥胖医学协会领导层的同行评审。

结果

本CPS概述了医学、饮食和身体活动史以及体格检查的重要组成部分,重点关注肥胖前期或肥胖患者管理中独特的特定方面。肥胖前期/肥胖患者与体脂未增加的患者一样,可从相同的预防性护理和常规实验室检查中获益。此外,肥胖前期/肥胖患者根据其临床表现和临床判断,可能从针对肥胖的特异性诊断检查中普遍或个别地获益。身体成分检测,如双能X线吸收法、生物电阻抗法和其他方法,各有其优缺点。一些临床研究中的患者,甚至可能在临床实践中,可能从能量消耗评估中获益。这可以通过几种方法实现,包括直接测热法、间接测热法、双标记水法或通过公式估算。最后,关于肥胖前期/肥胖病因和肥胖治疗效果的一个统一主题集中在生物和行为效率及低效率的作用上,效率提高通常与脂肪量增加相关,而低效率通常与脂肪量减少相关。

结论

肥胖医学协会(OMA)关于病史、体格检查、身体成分和能量消耗的临床实践声明(CPS)是OMA一系列CPS之一,旨在协助临床医生护理肥胖前期/肥胖疾病患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/4949ba3d2f75/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/a327cf8b8aee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/000c4e8e4789/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/4949ba3d2f75/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/a327cf8b8aee/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/000c4e8e4789/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3205/10661987/4949ba3d2f75/gr3.jpg

相似文献

1
Obesity history, physical exam, laboratory, body composition, and energy expenditure: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.肥胖病史、体格检查、实验室检查、身体成分和能量消耗:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Jan 10;1:100007. doi: 10.1016/j.obpill.2021.100007. eCollection 2022 Mar.
2
Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.肥胖的定义、诊断、偏差、标准操作程序(SOP)以及远程医疗:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Jan 15;1:100004. doi: 10.1016/j.obpill.2021.100004. eCollection 2022 Mar.
3
Behavior, motivational interviewing, eating disorders, and obesity management technologies: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.行为、动机性访谈、饮食失调与肥胖管理技术:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Mar 24;2:100014. doi: 10.1016/j.obpill.2022.100014. eCollection 2022 Jun.
4
Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.合并用药、功能性食品及营养补充剂:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Apr 6;2:100017. doi: 10.1016/j.obpill.2022.100017. eCollection 2022 Jun.
5
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.30个关于肥胖的误区、误解和/或过度简化观点:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Aug 10;3:100034. doi: 10.1016/j.obpill.2022.100034. eCollection 2022 Sep.
6
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.癌症与肥胖:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Jul 5;3:100026. doi: 10.1016/j.obpill.2022.100026. eCollection 2022 Sep.
7
Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.非酒精性脂肪性肝病与肥胖症:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Jul 8;3:100027. doi: 10.1016/j.obpill.2022.100027. eCollection 2022 Sep.
8
Stress, psychiatric disease, and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.压力、精神疾病与肥胖:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Nov 4;4:100041. doi: 10.1016/j.obpill.2022.100041. eCollection 2022 Dec.
9
Bariatric surgery, gastrointestinal hormones, and the microbiome: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.减肥手术、胃肠激素与微生物群:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Apr 1;2:100015. doi: 10.1016/j.obpill.2022.100015. eCollection 2022 Jun.
10
Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.睡眠呼吸障碍、睡眠呼吸暂停及其他与肥胖相关的睡眠障碍:肥胖医学协会(OMA)2022年临床实践声明(CPS)
Obes Pillars. 2022 Nov 15;4:100043. doi: 10.1016/j.obpill.2022.100043. eCollection 2022 Dec.

引用本文的文献

1
Novel Resting Energy Expenditure Prediction Equations for Multi-Ethnic Asian Older Adults with Multimorbidity.针对患有多种疾病的多民族亚洲老年人的新型静息能量消耗预测方程。
Nutrients. 2025 Jun 27;17(13):2144. doi: 10.3390/nu17132144.
2
Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition.肥胖的慢性化以及早期治疗对于降低心血管代谢风险和改善身体成分的重要性。
Obes Pillars. 2025 Apr 2;15:100175. doi: 10.1016/j.obpill.2025.100175. eCollection 2025 Sep.
3
Obesity management in primary care: A joint clinical perspective and expert review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025.

本文引用的文献

1
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer.高胰岛素血症及其在衰老、肥胖、2 型糖尿病、心血管疾病和癌症中的关键作用。
Int J Mol Sci. 2021 Jul 21;22(15):7797. doi: 10.3390/ijms22157797.
2
Hyperinsulinemia in Obesity, Inflammation, and Cancer.肥胖、炎症与癌症中的高胰岛素血症
Diabetes Metab J. 2021 Jul;45(4):622. doi: 10.4093/dmj.2021.0131. Epub 2021 Jul 30.
3
Reference values of body composition parameters and visceral adipose tissue (VAT) by DXA in adults aged 18-81 years-results from the LEAD cohort.
基层医疗中的肥胖管理:肥胖医学协会(OMA)和美国整骨疗法家庭医师学会(ACOFP)——2025年联合临床观点与专家综述
Obes Pillars. 2025 Mar 17;14:100172. doi: 10.1016/j.obpill.2025.100172. eCollection 2025 Jun.
4
Using Metabolic Testing to Personalize Behavioral Obesity Treatment.利用代谢测试实现行为性肥胖治疗的个性化。
Obes Sci Pract. 2025 Mar 11;11(2):e70065. doi: 10.1002/osp4.70065. eCollection 2025 Apr.
5
Neuroprotective effect of niacin in a rat model of obesity induced by high-fat-rich diet.烟酸对高脂饮食诱导的肥胖大鼠模型的神经保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 16. doi: 10.1007/s00210-024-03687-3.
6
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs.服用胰高血糖素样肽-1(GLP-1)和双重葡萄糖依赖性促胰岛素多肽(GIP)/GLP-1受体激动剂患者的饮食摄入:一项叙述性综述及研究需求讨论
Obes Pillars. 2024 Jul 25;11:100121. doi: 10.1016/j.obpill.2024.100121. eCollection 2024 Sep.
7
Obesity and advocacy: A joint clinical perspective and expert review from the obesity medicine association and the obesity action coalition - 2024.肥胖与倡导:肥胖医学协会和肥胖行动联盟的联合临床视角与专家综述 - 2024年
Obes Pillars. 2024 Jul 18;11:100119. doi: 10.1016/j.obpill.2024.100119. eCollection 2024 Sep.
8
What are the important factors influencing the physical activity level of junior high school students: a cross-sectional survey.影响初中生身体活动水平的重要因素有哪些:一项横断面调查。
Front Public Health. 2024 May 16;12:1380290. doi: 10.3389/fpubh.2024.1380290. eCollection 2024.
9
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.肥胖、血脂异常与心血管疾病:肥胖医学协会和国家脂质协会2024年联合专家综述
Obes Pillars. 2024 Mar 12;10:100108. doi: 10.1016/j.obpill.2024.100108. eCollection 2024 Jun.
10
Trend in the Prevalence of Overweight and Obese Adults in São Paulo, Brazil: Analysis between the Years 2006 and 2019.巴西圣保罗超重和肥胖成年人患病率趋势:2006年至2019年分析
Int J Environ Res Public Health. 2024 Apr 19;21(4):502. doi: 10.3390/ijerph21040502.
18-81 岁成年人 DXA 体成分参数和内脏脂肪组织 (VAT) 的参考值-来自 LEAD 队列的结果。
Eur J Clin Nutr. 2020 Aug;74(8):1181-1191. doi: 10.1038/s41430-020-0596-5. Epub 2020 Mar 2.
4
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.腰围作为临床实践中的生命体征:IAS 和 ICCR 内脏肥胖工作组的共识声明。
Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4.
5
Defining cutoffs to diagnose obesity using the relative fat mass (RFM): Association with mortality in NHANES 1999-2014.使用相对脂肪量 (RFM) 定义肥胖的切点:与 NHANES 1999-2014 年死亡率的关联。
Int J Obes (Lond). 2020 Jun;44(6):1301-1310. doi: 10.1038/s41366-019-0516-8. Epub 2020 Jan 7.
6
Body Composition Analysis of Computed Tomography Scans in Clinical Populations: The Role of Deep Learning.临床人群 CT 扫描的体成分分析:深度学习的作用。
Lifestyle Genom. 2020;13(1):28-31. doi: 10.1159/000503996. Epub 2019 Dec 10.
7
Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases.线粒体解偶联:生理学和疾病中生物过程的关键控制器。
Cells. 2019 Jul 30;8(8):795. doi: 10.3390/cells8080795.
8
Testing Bioimpedance to Estimate Body Fat Percentage across Different Hip and Waist Circumferences.通过生物电阻抗测试评估不同臀围和腰围人群的体脂百分比
J Sports Med (Hindawi Publ Corp). 2019 Jun 11;2019:7624253. doi: 10.1155/2019/7624253. eCollection 2019.
9
Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview.应用生物电阻抗分析(BIA)和双能 X 射线吸收法(DXA)评估健康和疾病中的人体成分:批判性综述。
Contrast Media Mol Imaging. 2019 May 29;2019:3548284. doi: 10.1155/2019/3548284. eCollection 2019.
10
Metabolic adaptation is not observed after 8 weeks of overfeeding but energy expenditure variability is associated with weight recovery.代谢适应在过度喂养 8 周后不会被观察到,但能量消耗变异性与体重恢复有关。
Am J Clin Nutr. 2019 Oct 1;110(4):805-813. doi: 10.1093/ajcn/nqz108.